---
$id: https://graph.org.ai/products/commodity/51102876
$type: Product
source: UNSPSC
code: "51102876"
title: "Ambroxol/cefadroxil"
class: "51102800"
classTitle: "Combination anti-infectives"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ambroxol/cefadroxil

**UNSPSC Code**: 51102876
**Class**: [Combination anti-infectives](Combination anti-infectives.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug composed of two constituents: a mucolytic and a cephalosporin antibiotic, as more fully appears. The first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula C13H18BR2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 200168S0CL, chemically known as 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [EU/ESIS 242-500-3]; ambroxol comes in forms acefyllinate [0HM1E174TN], base, and hydrochloride [CC995ZMV90]. European Medicines Agency schedules AMBROXOL in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05397MIG (base), SUB12842MIG (acefyllinate), and SUB00427MIG (hydrochloride). The term AMBROXOL is an International Non-Proprietary Name or INN. World Health Organization schedules ambroxol in its Anatomical Therapeutic Chemical (ATC) Classification (R05CB06) and in its WHO Drug Dictionary. AMBROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ambroxol under HS 29221980 and SITC 51461. US Census, for industry purposes, classifies ambroxol under NAICS 325199. The second constituent, Cefadroxil (51282502), is a cephalosporin antibiotic with the molecular formula C16H17N3O5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 280111G160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefadroxil, which bears US NIH Compound Identifier 2610. Cefadroxil most often comes in base, hydrate, and hemihydrate forms. European Medicines Agency schedules Cefadroxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06164MIG. World Health Organization schedules cefadroxil in its Anatomical Therapeutic Chemical (ATC) Classification. CEFADROXIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefadroxil under HS 29419000 and SITC 54139. As of Q4 2014, CEFADROXIL remains the US FDA Preferred Term for this commodity. Cefadroxil bears US NLM identifiers UMLS ID C0007538 and NCI Concept Code C28912.

